April 28, 2017 5:26 PM ET


Company Overview of Neurovance, Inc.

Key Executives for Neurovance, Inc.

NameBoard RelationshipsTitleAge
Jeffrey Allen Bailey 30 RelationshipsExecutive Chairman and Chief Executive Officer53
Anthony A. McKinney M.B.A.8 RelationshipsFounder, Chief Development Officer and Director--
William T. Pappafotopoulos MBANo RelationshipsVice President of Finance and Administration--
Brian Goff M.B.A.7 RelationshipsChief Operating Officer and Director47
Catherine O'Brien No RelationshipsDirector of Clinical Operations--

Neurovance, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Jeffrey Allen Bailey 30 RelationshipsNeurovance, Inc.53
Anthony A. McKinney M.B.A. 8 RelationshipsEBI Life Sciences, Inc.--
Brian Goff M.B.A. 7 RelationshipsNeurovance, Inc.47
Campbell Murray M.D. 38 RelationshipsNovartis Venture Fund39
Paul M. K. Weiss Ph.D., MBA 76 RelationshipsProCertus BioPharm, Inc.59
View All Board Members

Neurovance, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Neurovance, Inc. CEO Compensation
Industry Average


Praxsyn Corporation Promotes Stephanie Kaitz to the Position of Financial Controller
April 27, 2017 1:30 PM ET
Allergan plc Appoints Hani Zeini as Strategic Advisor
April 27, 2017 12:00 PM ET
Jerome B. Zeldis Resigns from the Board of Directors of AIT Therapeutics, Inc
April 27, 2017 11:29 AM ET
Rgenix, Inc. Appoints Roger Waltzman as Chief Medical Officer
April 27, 2017 11:00 AM ET
scPharmaceuticals, Inc. Appoints John Tucker as President, Chief Executive Officer and to the Board of Directors
April 26, 2017 2:45 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neurovance, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.